Suchergebnisse - "rucaparib"

PubPharm (7)

1

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer : final results from Study 10

enthalten in: British journal of cancer | 2023

von Kristeleit, R. | Drew, Y. | Oza, A. | +13

2

Genetic aberrations in DNA repair pathways : a cornerstone of precision oncology in prostate cancer

enthalten in: British journal of cancer | 2021

von Lozano, R. | Castro, E. | Aragón, I. | +4

3

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours

enthalten in: British journal of cancer | 2017

von Wilson, R. | Evans, T. | Middleton, M. | +8

4

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

enthalten in: British journal of cancer | 2016

von Drew, Y. | Ledermann, J. | Hall, G. | +14

CommentIn: Br J Cancer. 2016 Mar 29;114(7):713-5. - PMID 27022824

5

Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase

enthalten in: British journal of cancer | 2014

von Znojek, P. | Willmore, E. | Curtin, N.

6

Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules

enthalten in: British journal of cancer | 2014

von Murray, J. | Thomas, H. | Berry, P. | +8

7

Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699

enthalten in: British journal of cancer | 2010

von Daniel, R. | Rozanska, A. | Mulligan, E. | +9

1
[1]